Type 2 Diabetes Mellitus study: Continuous glucose monitor
Official title Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
ClinicalTrials.gov ID: NCT07065721
What this study is testing
- What it's testing
- The study wants to learn what helps or hinders people using CGMs, how it changes their awareness of blood sugar, and what they prefer for future self‑management tools.
- Who it's for
- Young adults who have type 2 diabetes.
- What's involved
- Participants will wear a CGM for 30 days, share their experiences, and answer questions about using the device.
- Time commitment
- The study lasts about a month, with daily CGM use and a few check‑in visits or calls to discuss the experience.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- adult 18-45 years of age
- diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
- no prior use or experience with wearable CGMs
- possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize...
- fluency in English or Spanish
You likely can't join if
- severe mental illness (e.g., psychosis, suicidal ideation);
- pregnancy or \<6 months postpartum
The study team makes the final eligibility decision.
Where it is enrolling
- San Diego, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at San Diego, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.